Pacira | PCRX - Interest Income


Pacira reported $8.53M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Astellas Pharma JPY 4.12B 2.94B Mar/2024
Cara Therapeutics USD 347K 74K Mar/2025
Heron Therapeutics USD 433K 277K Dec/2021
Ironwood Pharmaceuticals USD 778K 374K Dec/2024
J&J USD 2.14 237M Mar/2026
Ligand Pharmaceuticals USD 3.87M 2.25M Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 8.53M 3.53M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Supernus Pharmaceuticals USD 2.28M 2.25M Sep/2025
Xeris Pharmaceuticals USD 1.16M 210K Sep/2025
Zoetis USD 26M 7M Sep/2025